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From January to June 2018, two ongoing hepatitis A 
outbreaks affected travellers returning from Morocco 
and cases in Europe without travel history, resulting in 
163 patients in eight European countries. Most inter-
viewed travel-related cases were unaware of the hepa-
titis A risk in Morocco. Molecular analysis revealed 
two distinct hepatitis A virus (HAV) strains (subgeno-
type IA DK2018_231; subgenotype IB V18–16428). 
Vaccination recommendations should be emphasised 
to increase awareness among non-immune travellers 
to Morocco and HAV-endemic countries.
We report on two distinct hepatitis A virus strains that 
are causing cases in travellers returning from Morocco 
and autochthonous cases in several European coun-
tries between 1 January and 18 June 2018.
The alert
 On 2 May 2018, Denmark reported a cluster of hepatitis 
A virus (HAV) infections with the subgenotype IA 
strain DK2018_231, through the European Centre for 
Disease Prevention and Control (ECDC)’s Epidemic 
Intelligence Information System (EPIS) for food- and 
waterborne diseases and zoonoses (FWD). One of the 
three confirmed cases had travelled to Morocco. In 
response, five additional European Union (EU) coun-
tries (France, Germany, the Netherlands, Spain and the 
United Kingdom (UK)) reported cases (n = 20) infected 
with the same strain between 21 January and 10 April 
2018. Concurrently, Germany reported to EPIS that it 
observed more cases of hepatitis A with travel history 
to Morocco than expected, compared with the same 
period in the previous 5 years. Molecular analysis of 
the HAV VP1/P2A region revealed an unrelated cluster 
of the HAV subgenotype IB strain V18–16428. Cases 
infected with this unrelated strain were also reported 
from France, the Netherlands, Sweden and UK.
The appearance of clusters with a link to Morocco trig-
gered further epidemiological investigations.
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Case definitions and outbreak curve
For the investigation of the two clusters, the case defi-
nitions in the  Box  were used. The  Figure  shows the 
epidemiological curve depicting both clusters.
Subgenotype IA cluster (DK2018_231) 
As at 18 June 2018, 55 cases belonging to the subgen-
otype IA-cluster were reported from eight European 
countries. The UK reported the highest number of 
cases (n = 36). Denmark, France, Germany, Ireland, the 
Netherlands, Spain and Sweden each reported between 
one and six cases. Some few cases (n = 22/55) iden-
tified in Ireland, Spain and the UK differ from strain 
DK2018_231 by one or two nucleotides in the VP1/P2A 
junction.
Onset of symptoms among the cases ranged between 
mid-January and mid-June 2018. Cases were between 3 
and 81 years old with a median of 31 years (interquar-
tile range (IQR): 12.5–52 years); 47% (n = 26/55) were 
female. Three cases reported travel to Morocco within 
50 days before disease onset; one case in their early 
50s who had no known pre-existing conditions, died as 
a result of HAV infection.
Variants of strain DK2018_231 differing by only one or 
two nucleotides are considered as part of this cluster. 
The occurrence of closely related strains of HAV have 
been observed in other major food-borne outbreaks 
[1-3]. It is, however, still possible that cases actually 
belong to separate transmission chains.
Travel-related confirmed cases
  • An EU/EEA resident with laboratory-confirmed hepatitis A and date of symptoms onset (or date of sampling if onset date not 
available or if the case is asymptomatic) on or after 1 January 2018 
 
and 
 
  • with a travel history to Morocco in the 50 days before symptoms onset 
 
And
Cluster with subgenotype IA Cluster with subgenotype IB
  • a sequence with ≥ 99.4% identity to the HAV subgenotype 
IA outbreak strain DK2018_231, based on an overlapping 
fragment at the VP1/P2A region.
  • a sequence with ≥ 99.4% identity to the HAV subgenotype IB 
outbreak strain V18–16428, based on an overlapping fragment at the 
VP1/P2A region.
Autochthonous confirmed cases
  • An EU/EEA resident with laboratory-confirmed hepatitis A and date of symptoms onset (or date of sampling if onset date not 
available or if the case is asymptomatic) on or after 1 January 2018 
 
and 
 
  • without a travel history out of the EU/EEA in the 50 days before symptoms onset 
 
And
Cluster with subgenotype IA Cluster with subgenotype IB
  • a sequence with ≥ 99.4% identity to the HAV subgenotype 
IA outbreak strain DK2018_231, based on an overlapping 
fragment at the VP1/P2A region
  • a sequence with ≥ 99.4% identity to the HAV subgenotype IB 
outbreak strain V18–16428, based on an overlapping fragment at the 
VP1/P2A region
Travel-related possible cases
  • An EU/EEA resident with laboratory-confirmed hepatitis A and date of symptoms onset (or date of sampling if onset date not 
available or if the case is asymptomatic) on or after 1 January 2018 
 
and 
 
  • with a travel history to Morocco in the 50 days before symptoms onset 
 
and 
 
  • without sequencing characterisation of the viral RNA.
Box
Case definitions for confirmed travel-related or autochthonous hepatitis A cases infected with the subgenotype IA virus 
strain DK2018_231 or the subgenotype IB virus strain V18–16428
EU/EEA: European Union/European Economic Area; HAV: hepatitis A virus.
In order to consider possible mutations, we included closely related strains with a cut-off of 2 nucleotides (99.4% identity) in the case 
definition.
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Subgenotype IB cluster (V18–16428) 
As at 18 June 2018, the subgenotype IB-cluster con-
sisted of 33 confirmed cases; 25 travel-related and 
eight autochthonous (Table). Most cases were reported 
by Germany (n = 15), France (n = 8) and the UK (n = 6), 
with Sweden and the Netherlands only reporting one 
and three cases, respectively. Sequencing results of 
the VP1/P2A junctions revealed a 100% identity. Onset 
of symptoms ranged from the beginning of April to mid-
May. All travel-related cases reported travel to Morocco 
in March. The overall age range of cases were between 
8 and 76 years, with a median of 51 years (IQR: 26–61 
years); 55% (n = 18/33) were female
Early results from case interviews in 
Germany and France 
The travel-related cases in Germany were initially sus-
pected to belong to the IA cluster, but the sequencing 
results revealed a different subgenotype. A case–con-
trol study of the German cases is underway, and 16 
travel-related cases (8 confirmed, 8 possible) and four 
autochthonous cases have been interviewed so far for 
potential exposures. All autochthonous cases have 
reported consumption of food items brought home by 
travellers returning from Morocco, with dates being the 
only food item reported by all four cases. Among the 
16 travel-associated cases, 14 reported date consump-
tion during their stay in Morocco. In France, one patient 
reported bringing dates back from Morocco and eat-
ing these together with two other persons, all three of 
whom developed symptoms after the same incubation 
time.
Based on these preliminary results, dates are currently 
the suspected vehicle in this cluster, though investiga-
tion is ongoing.
Vaccination status
Information regarding hepatitis A vaccination status 
was collected from the German travel-related cases 
via interview, including reasons for non-vaccination. 
Preliminary results show that of the 15 travel-related 
Figure 
Number of hepatitis A virus cases by case definition, hepatitis A virus subgenotype cluster and week of disease onset, 1 
January–18 June 2018 (n = 163)
0
5
10
15
20
25
30
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Nu
m
be
r o
f o
ut
br
ea
k 
ca
se
s
Onset of disease (week) 
2018
Possible travel-related case
IA — autochthonous case
IA — travel-related case
IB — autochthonous case
IB — travel-related case
IA: subgenotype IA, strain DK2018_231; IB: subgenotype IB strain V18–16428.
4 www.eurosurveillance.org
cases (one case refused to be re-interviewed), 13 were 
either not vaccinated or unsure of their vaccination sta-
tus. Eleven cases stated that they had been unaware of 
the risk of HAV in Morocco, while six reported that they 
did not know there was a vaccination against hepati-
tis A. During the interviews, several cases stated that 
there was a lack of information regarding vaccination 
recommendations for Morocco in the travel guides and 
tour operator documents they had used when prepar-
ing for their trip.
Unvaccinated travel-related cases were also reported 
from Denmark (n = 3), France (n = 41), the Netherlands 
(n = 3) and Spain (n = 5); reasons for non-vaccination 
were not collected. Vaccination status was not avail-
able for all other travel-related cases from these coun-
tries or from Ireland, Sweden and the UK.
Discussion and conclusion
The occurrence of the two concurrent HAV clusters 
in the first 6 months of 2018 serve as a reminder of 
the risk of contracting hepatitis A in Morocco, a coun-
try with intermediate endemicity [4,5]. HAV subgeno-
types IA and IB are known to circulate in Morocco 
and strain DK2018_231 has been observed in spo-
radic cases with travel history to Morocco in previous 
years [6-8]. Despite the different characteristics of the 
two reported clusters, cases with a travel history to 
Morocco feature in both. In a recent study of European 
travellers, Turkey, Egypt and Morocco were listed as 
the top three destinations for acquiring travel-associ-
ated hepatitis A and accounted for one third of cases 
in the period 2009–15 [9]. The epidemiological link 
to Morocco is more apparent in cluster IB, where the 
majority of cases had confirmed travelling to Morocco 
and all interviewed autochthonous cases had reported 
consuming food items brought home from there.
In the IA cluster, only three cases had travelled 
to Morocco. However, the large proportion of 
autochthonous cases and their spatial distribution in 
this cluster suggest that an imported food item may 
have served as the vehicle in this outbreak. Large 
food-borne hepatitis A outbreaks from frozen berries 
and semi-dried tomatoes have previously affected 
European countries, further indicating that imported 
contaminated food products pose a risk to the increas-
ingly susceptible general population in Europe [10-13].
The outbreaks described here illustrate the increased 
risk that non-immune travellers face when visiting HAV-
endemic areas like Morocco. All of the eight countries 
where cases occurred have explicit recommendations 
of hepatitis A vaccination for travel to endemic coun-
tries, in accordance with World Health Organization 
(WHO) recommendations [14,15]. Yet it appears that 
it is not uncommon for people to travel unvaccinated 
to HAV-endemic countries. An outbreak investigation 
of hepatitis A in travellers to Egypt between 2012 and 
2013 found a high proportion of travellers who were 
not immunised before travelling [16,17]. Interviews with 
the German cases have rendered similar results, sug-
gesting that there may be an information gap regarding 
both the risk of hepatitis A and the availability of a safe 
and effective vaccine.
Conclusions
Thus, vaccination recommendations for hepatitis A 
need to be repeatedly emphasised, particularly before 
and during peak travel seasons. In order to better 
reach individuals travelling to endemic countries, we 
propose engaging travel companies and airlines to 
inform and remind travellers about vaccination recom-
mendations, as has been suggested by others [16,18]. 
Special attention should also be given to populations 
with a Moroccan origin living in the EU/EEA, who may 
regularly be travelling to Morocco. These populations 
need to be alerted that particularly their children are 
most likely susceptible to HAV infection and should be 
vaccinated [19]. Finally, as hepatitis A vaccination does 
Table
Number of travel-related and autochthonous cases of hepatitis A, by country of origin and hepatitis A virus subgenotype, 1 
January–18 June 2018 (n = 163)
Number of confirmed cases, subgenotype IA, 
DK2018_231
Number of confirmed cases, subgenotype IB, 
V18–16428
Number of possible 
cases
Country of origin Travel-related Autochthonous Travel-related Autochthonous Travel-related
Denmark 1 5 0 0 2
France 1 0 6 2 43
Germany 1 0 9 6 15
Ireland 0 1 0 0 0
The Netherlands 0 4 3 0 1
Spain 0 5 0 0 14
Sweden 0 1 1 0 0
UK 0 36 6 0 0
Total 3 52 25 8 75
UK: United Kingdom.
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not protect from many other food-borne infections 
additional recommendations to follow sound hygiene 
including hand hygiene should be given to the public.
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